AliciaWidgeMDMS

Pediatric Asthma & Allergic Conditions

National Institutes of Health, Allergy/Immunology Fellow

Dr. Widge is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Children's National HospitalResidency, Pediatrics, 2014 - 2017
George Washington University School of Medicine and Health SciencesClass of 2014

PubMed

Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine.
Joseph P Casazza, Amelia R Hofstetter, Pamela J M Costner, LaSonji A Holman, Cynthia S Hendel
NPJ Vaccines. 2024-09-17
28 citations
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.
Alicia T Widge, Amelia R Hofstetter, Katherine V Houser, Seemal F Awan, Grace L Chen
Science Translational Medicine. 2023-04-19
26 citations
An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans.
Sarah F Andrews, Lauren Y Cominsky, Geoffrey D Shimberg, Rebecca A Gillespie, Jason Gorman
Science Translational Medicine. 2023-04-19

‘We Just Have to Keep Pushing’: Universal Flu Vaccine Remains Out of Reach, for NowNovember 3rd, 2021
Vaccine Makers Bet on mRNA Technology to Improve Future Flu ShotsOctober 11th, 2021
First, Impressive Vaccines for Covid. Next up: The FluOctober 9th, 2021
Join now to see all